ABT has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
This is the expense the company spent on research and development. Abbott Laboratories's research and development for the three months ended in Mar. 2014 was $387 Mil. Its research and development for the trailing twelve months (TTM) ended in Mar. 2014 was $1,493 Mil.
This is the expense the company spent on research and development.
Abbott Laboratories Research & Development for the trailing twelve months (TTM) ended in Mar. 2014 was 362.557 (Jun. 2013 ) + 356.877 (Sep. 2013 ) + 386.243 (Dec. 2013 ) + 387 (Mar. 2014 ) = $1,493 Mil.
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
If competitive advantage is created by a patent or tech advantage, at some point it will disappear.
High R&D usually dictates high SG&A which threatens the competitive advantage.
Abbott Laboratories Annual Data
|Research & Development||1,697||1,821||2,255||2,506||2,689||2,914||3,724||4,129||1,544||1,452|
Abbott Laboratories Quarterly Data
|Research & Development||1,152||364||371||351||460||346||363||357||386||387|